MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.breast.2025.104559

Медицинская библиотека · Breast (Edinburgh, Scotland) · 2025

Feasibility of the omission of axillary surgery in node-negative early breast cancer: a systematic review and meta-analysis.

Lucocq James, Baig Hassan, Elder Kenneth, Urquhart Gordon, Sharma Ravi, Romics Laszlo, Elsberger Beatrix

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

INTRODUCTION

Recent and historical trials have suggested that the omission of axillary surgery is oncologically safe in node-negative early breast cancer. This meta-analysis investigates the feasibility of the omission of axillary surgery (SLNB or ALND) in terms of oncological outcomes and adjuvant treatment decisions.

METHOD: A systematic search of Medline, Embase and Cochrane Central was conducted. Random-effect meta-analysis was conducted to compare recurrence and survival outcomes between omission of axillary surgery and SLNB or ALND. Differences in real-world adjuvant treatment decisions and patient reported outcomes were investigated.

RESULTS

Ten studies (omission, n = 3716; SLNB/ALND, n = 4604/785) investigated oncological outcomes (pooled rates, T1 88 %; Grade 1-2 80 %; ER-positive 91.2 %; HER2-positive 4.4 %; ductal carcinoma 74 %). In the omitted group, the pooled rates of local, axillary and distant recurrence (follow-up, 8 years 9 months) were 3.0 % (95 %CI,1.5-5.9 %), 2.5 % (95 %CI,1.3-4.8 %; 5year, 1.0 %) and 3.6 % (95 %CI,2.0-6.5 %; 5year, 2.7 %), respectively. When comparing omission to SLNB/ALND, there were no differences in local recurrence (OR 0.91; 95 %CI,0.56-1.50), distant metastasis (OR 0.91; 95 %CI,0.56-1.50), BCM (OR 1.00; 95 %CI,0.63-1.60), OS (HR 0.88; 95 %CI,0.65-1.19) or DFS (HR 0.91; 95 %CI,0.76-1.11). Axillary recurrence was higher in the omission group compared to SLNB/ALND (OR 4.42; 95 %CI,1.5-12.8) but not in SLNB alone (OR 2.85; 95 %CI,0.1-133.8). Omission of axillary surgery was associated with lower rates of adjuvant chemotherapy, radiotherapy and hormonal treatment but quality of evidence was poor.

CONCLUSION

Omission of axillary surgery is safe in node-negative early breast cancer. Prospective data is required to investigate the impact of omission on adjuvant treatment decision.

Для цитирования: Lucocq James, Baig Hassan, Elder Kenneth, Urquhart Gordon, Sharma Ravi, Romics Laszlo, Elsberger Beatrix. Feasibility of the omission of axillary surgery in node-negative early breast cancer: a systematic review and meta-analysis.. Breast (Edinburgh, Scotland). 2025. DOI: 10.1016/j.breast.2025.104559.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.